Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Q3 2023 Standard BioTools Inc Earnings Call Transcript

Nov 07, 2023 / 09:30PM GMT
Release Date Price: $1.99 (-2.45%)
Operator

Hello, and welcome to the Standard BioTools' third-quarter 2023 financial results conference call. As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Peter DeNardo, Investor Relations. Thank you, Mr. DeNardo. You may begin.

Peter DeNardo
Standard BioTools Inc. - IR

Thank you, Rachel. Good afternoon, everyone. Welcome to Standard BioTools' third-quarter 2023 earnings conference call. At the close of the market today, Standard BioTools released its financial results for the quarter ended September 30, 2023. During this call, we will review our results and provide commentary on our financial and operational performance, market trends, and strategic initiatives.

Presenting for Standard BioTools today, we have Michael Egholm, Chief Executive Officer and President; and Jeff Black, Chief Financial Officer.

During the call, we may make forward-looking statements about events and circumstances that have not yet occurred, including plans or projections for our business, our outlook for 2023, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot